No picture, placeholder image
No picture, placeholder image
Department of Clinical Medicine stale.h.nymo@uit.no

Ståle Haugset Nymo



  • Mathias Øie Kolden, Ståle Haugset Nymo, Erik Øie :
    Impact of neighbourhood-level socioeconomic status, traditional coronary risk factors, and ancestry on age at myocardial infarction onset: A population-based register study
    BMC Cardiovascular Disorders 2022 DOI
  • Kiarash Tazmini, Mai Fraz, Ståle Haugset Nymo, Mathis Korseberg Stokke, William Edward Louch, Erik Øie :
    Potassium infusion increases the likelihood of conversion of recent-onset atrial fibrillation- A single-blinded, randomized clinical trial
    American Heart Journal 2020 ARKIV / DOI
  • Fizza Kanwal Arain, Judita Aurelija Abraityte, Mariia Bogdanova, Ole Geir Solberg, Annika Michelsen, Tove Lekva et al.:
    YKL-40 (Chitinase-3-Like Protein 1) Serum Levels in Aortic Stenosis
    Circulation: Heart Failure 2020 ARKIV / DOI
  • Alberto Aimo, James L. Januzzi, Giuseppe Vergaro, Aldo Clerico, Roberto Latini, Jennifer Meessen et al.:
    Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome
    European Journal of Preventive Cardiology (EJPC) 2019 ARKIV / DOI
  • Kiarash Tazmini, Ståle Haugset Nymo, William Edward Louch, Anette Hylen Ranhoff, Erik Øie :
    Electrolyte imbalances in an unselected population in an emergency department: A retrospective cohort study
    PLOS ONE 2019 ARKIV / DOI
  • William Ward Siljan, Jan Cato Holter, Annika Michelsen, Ståle Haugset Nymo, Trine Lauritzen, Kjersti Oppen et al.:
    Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: Results of a 5-year follow-up cohort study
    ERS Monograph 2019 ARKIV / DOI
  • Alberto Aimo, James L. Januzzi, Giuseppe Vergaro, Andrea Ripoli, Roberto Latini, Serge Masson et al.:
    Prognostic value of high-sensitivity troponin T in chronic heart failure an individual patient data meta-analysis
    Circulation 2018 DOI
  • William Ward Siljan, Jan Cato Holter, Ståle Haugset Nymo, Einar Husebye, Thor Ueland, Lillemor Skattum et al.:
    Low levels of immunoglobulins and mannose-binding lectin are not associated with etiology, severity, or outcome in community-acquired pneumonia
    Open Forum Infectious Diseases 2018 ARKIV / DOI
  • Ståle Haugset Nymo, Marianne Hartford, Thor Ueland, Arne Yndestad, Erik Lorentzen, Katarina Truvé et al.:
    Serum neutrophil gelatinase-associated lipocalin (NGAL) concentration is independently associated with mortality in patients with acute coronary syndrome
    International Journal of Cardiology 2018 ARKIV / DOI
  • Alberto Aimo, James L. Januzzi, Giuseppe Vergaro, Andrea Ripoli, Roberto Latini, Serge Masson et al.:
    High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure
    International Journal of Cardiology 2018 DOI
  • Michele Emdin, Alberto Aimo, Giuseppe Vergaro, Antoni Bayes-Genis, Josep Lupón, Roberto Latini et al.:
    sST2 predicts outcome in chronic heart failure beyond NT - proBNP and high-sensitivity troponin T
    Journal of the American College of Cardiology 2018 DOI
  • Ståle Haugset Nymo, Pål Aukrust, John Kjekshus, John J.V. McMurray, John G.F. Cleland, John Wikstrand et al.:
    Limited added value of circulating inflammatory biomarkers in chronic heart failure
    JACC. Heart failure 2017 DOI
  • William Ward Siljan, Jan Cato Holter, Ståle Haugset Nymo, Einar Husebye, Thor Ueland, Pål Aukrust et al.:
    Cytokine responses, microbial aetiology and short-term outcome in community-acquired pneumonia
    European Journal of Clinical Investigation 2017 ARKIV / DOI
  • Ståle Haugset Nymo, Thor Ueland, Erik Tandberg Askevold, Christen Peder Dahl, Lars Gullestad, Pål Aukrust et al.:
    Circulating nucleosomes in chronic heart failure
    International Journal of Cardiology 2016 DOI
  • Fizza Kanwal Arain, Lars Gullestad, Ståle Haugset Nymo, John Kjekshus, JG Cleland, Annika Michelsen et al.:
    Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA
    Biomarkers 2016 DOI
  • Øystein Sandanger, E Gao, Trine Ranheim, Marte Bliksøen, Ole Jørgen Kaasbøll, Katrine Alfsnes et al.:
    NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective
    Biochemical and Biophysical Research Communications - BBRC 2016 DOI
  • Thor Ueland, Pål Aukrust, Ståle Haugset Nymo, John Kjekshus, JJ McMurray, J Wikstrand et al.:
    Novel Extracellular Matrix Biomarkers as Predictors of Adverse Outcome in Chronic Heart Failure: Association Between Biglycan and Response to Statin Therapy in the CORONA Trial
    Journal of Cardiac Failure 2015 DOI
  • Thor Ueland, Pål Aukrust, Ståle Haugset Nymo, John Kjekshus, John J.V. McMurray, John Wikstrand et al.:
    Predictive Value of Endostatin in Chronic Heart Failure Patients with Poor Kidney Function
    Cardiology 2015 DOI
  • Thor Ueland, Lars Gullestad, Ståle Haugset Nymo, Arne Yndestad, Pål Aukrust, Erik Tandberg Askevold :
    Inflammatory cytokines as biomarkers in heart failure
    Clinica Chimica Acta 2015 DOI
  • Judita Aurelija Abraityte, Lars Gullestad, Erik Tandberg Askevold, Ståle Haugset Nymo, Christen Peder Dahl, Svend Aakhus et al.:
    The Notch ligand Delta-like 1 is elevated and associated with mortality in patients with symptomatic aortic stenosis
    International Journal of Cardiology 2015 DOI
  • Erik Tandberg Askevold, Lars Gullestad, Ståle Haugset Nymo, John Kjekshus, Arne Yndestad, Roberto Latini et al.:
    Secreted frizzled related protein 3 in chronic heart failure: Analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA)
    PLOS ONE 2015 ARKIV / DOI
  • Linn Elisabeth Lillerud Fosshaug, Christen Peder Dahl, Ivar Risnes, Pavol Bohov, Rolf Kristian Berge, Ståle Haugset Nymo et al.:
    Altered Levels of Fatty Acids and Inflammatory and Metabolic Mediators in Epicardial Adipose Tissue in Patients With Systolic Heart Failure
    Journal of Cardiac Failure 2015 DOI
  • Ingrid Kristine Ohm, Erhe Gao, Maria Belland Olsen, Katrine Alfsnes, Marte Bliksøen, Jonas Øgaard et al.:
    Toll-like receptor 9-activation during onset of myocardial ischemia does not influence infarct extension
    PLOS ONE 2014 DOI
  • Erik Tandberg Askevold, Pål Aukrust, Ståle Haugset Nymo, Ida Gjervold Lunde, Ole Jørgen Kaasbøll, Svend Aakhus et al.:
    The cardiokine secreted Frizzled related protein 3, a modulator of Wnt-signalling, in clinical and experimental heart failure
    Journal of Internal Medicine 2014 DOI
  • Ståle Haugset Nymo, Johannes Hulthe, Thor Ueland, John McMurray, John Wikstrand, Erik Tandberg Askevold et al.:
    Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA
    European Journal of Heart Failure 2014 DOI
  • Jørgen A. Gravning, Erik Tandberg Askevold, Ståle Haugset Nymo, Thor Ueland, John Wikstrand, John J.V. McMurray et al.:
    Prognostic effect of high-sensitive troponin t assessment in elderly patients with chronic heart failure results from the CORONA Trial
    Circulation: Heart Failure 2014 DOI
  • Thor Ueland, Ståle Haugset Nymo, Roberto Latini, John J.V. McMurray, John Kjekshus, Arne Yndestad et al.:
    CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials
    European Journal of Heart Failure 2013 DOI
  • Lars Gullestad, Thor Ueland, John Kjekshus, Ståle Haugset Nymo, Johannes Hulthe, Pieter Muntendam et al.:
    Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
    European Heart Journal 2012 DOI
  • Kaspar Broch, Thor Ueland, Ståle Haugset Nymo, John Kjekshus, Johannes Hulthe, Pieter Muntendam et al.:
    Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology
    European Journal of Heart Failure 2012 DOI
  • R Latini, Lars Gullestad, S Masson, Ståle Haugset Nymo, Thor Ueland, I Cuccovillo et al.:
    Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials
    European Journal of Heart Failure 2012 DOI
  • Lars Gullestad, Thor Ueland, John Kjekshus, Ståle Haugset Nymo, Johannes Hulthe, Pieter Muntendam et al.:
    The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
    American Heart Journal 2012 DOI
  • Ståle Haugset Nymo, Thor Ueland, Erik Tandberg Askevold, Trude Helen Flo, John Kjekshus, Johannes Hulthe et al.:
    The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA
    Journal of Internal Medicine 2012 DOI
  • Erik Tandberg Askevold, Ståle Haugset Nymo, Thor Ueland, Jørgen A. Gravning, Ragnhild Wergeland, John Kjekshus et al.:
    Soluble Glycoprotein 130 predicts Fatal Outcomes in Chronic Heart Failure: Analysis From the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
    Circulation: Heart Failure 10. December 2012 DATA / DOI
  • Sverre Holm, Thor Ueland, Tuva Børresdatter Dahl, Annika Michelsen, Mona Skjelland, David Russell et al.:
    Fatty Acid Binding Protein 4 Is Associated with Carotid Atherosclerosis and Outcome in Patients with Acute Ischemic Stroke
    PLOS ONE 2011 DOI
  • Marianne Ask Torvik, Stig Haugset Nymo, Ståle Haugset Nymo, Lars Petter Bache-Wiig Bjørnsen, Hanne Winge Kvarenes, Eirik Hugaas Ofstad :
    Patient characteristics in sepsis-related deaths: prevalence of advanced frailty, comorbidity, and age in a Norwegian hospital trust (Infection, (2023), 10.1007/s15010-023-02013-y)
    Infection 2023 DOI
  • Helge Ingvart Fredriksen, Asal Asgari, Ståle Haugset Nymo :
    Clustering clinical multivariate time-series with variable lengths and irregularsampling intervals.
    2023
  • Mathias Øie Kolden, Ståle Haugset Nymo, Erik Øie :
    Correction: Impact of neighbourhood-level socioeconomic status, traditional coronary risk factors, and ancestry on age at myocardial infarction onset: A population-based register study (BMC Cardiovascular Disorders, (2022), 22, 1, (447), 10.1186/s12872-022-02880-7)
    BMC Cardiovascular Disorders 2022 DOI
  • William Ward Siljan, Jan Cato Holter, Annika Elisabet Michelsen, Ståle Haugset Nymo, Jon Norseth, Einar Husebye et al.:
    Procalcitonin has wider applicability in community-acquired pneumonia than other biomarkers
    European Respiratory Journal 2018 DOI
  • William Siljan, Jan Cato Holter, Ståle Haugset Nymo, Camilla Schjalm, Fredrik Müller, Pål Jenum et al.:
    Circulating cell-free DNA is elevated in community-acquired bacterial pneumonia and predicts short-term outcome
    Journal of Infection 2016 DOI
  • Christen Peder Dahl, Pål Aukrust, Ståle Haugset Nymo, John Kjekshus, John G.F. Cleland, John J. V. McMurray et al.:
    Prognostic value of CXCL16 in patients with left ventricular systolic dysfunction and heart failure
    International Journal of Cardiology 2013 DOI
  • Linn E Fosshaug, Christen Peder Dahl, Ivar Risnes, OK Olstad, R.K. Berge, Ståle Haugset Nymo et al.:
    Palmitoleate is increased in epicardial adopose tissue in heart failure and correlates with parameters of progressing failure
    European Heart Journal 2012
  • Jørgen A. Gravning, Erik Tandberg Askevold, Ståle Haugset Nymo, Thor Ueland, Ragnhild Wergeland, J Wikstrand et al.:
    Prognostic impact of high-sensitive troponin T assessment in chronic heart failure and interaction with statin therapy. Results from CORONA
    European Heart Journal 2012

  • The 50 latest publications is shown on this page. See all publications in Cristin here →